|
| control group x±s/n | experimental group x±s/n | χ2 | P |
Gender | Male | 14 | 16 | 0.139 | 0.709 |
| Famale | 46 | 44 |
|
|
Age |
| 60.37 ± 7.09 | 61.09 ± 6.95 | 0.058 | 0.810 |
Tumor types | Cervical cancer | 35 | 33 |
|
|
| Endometrial cancer | 10 | 9 | 0.876 | 0.831 |
| Bladder cancer | 7 | 10 |
|
|
| Prostate Cancer | 8 | 8 |
|
|
KPS |
| 89.17 ± 6.96 | 88.50 ± 7.09 | 0.01 | 0.918 |
Surgery | Yes | 38 | 36 | 0.001 | 0.984 |
| No | 22 | 21 |
|
|
Concurrent chemotherapy | Yes | 20 | 18 | 0.041 | 0.839 |
| No | 40 | 39 |
|
|
Small intestine exposure dose | Dmax ≤ 52 Gy and V50 < 5% Dmax ≤ 52 Gy and V50 ≥ 5% | 59
1
| 55
2
| 0.397 | 0.612 |
Rectum exposure dose | V50<50% V50≥50% | 57 3 | 53 4 | 0.212 | 0.712 |